HPTN Publications

Zhang J, Brown ER . Estimating the effectiveness in HIV prevention trials by incorporating the exposure process: Application to HPTN 035 data. Biometrics. 2014, 70: 745-53

Zhang Y, Clarke W, Marzinke MA, Piwowar-Manning E, Beauchamp G, Breaud A, Hendrix CW, Cloherty GA, Emel L, Rose S, Hightow-Weidman L, Siegel M, Shoptaw S, Fields SD, Wheeler D, Eshleman SH . Evaluation of a Multidrug Assay for Monitoring Adherence to a Regimen for HIV Pre-exposure Prophylaxis in a Clinical Study, HIV Prevention Trials Network 073.. Antimicrob Agents Chemother. 2017, 61

Zhang Y, Fogel JM, Guo X, Clarke W, Breaud A, Cummings V, Hamilton EL, Ogendo A, Kayange N, Panchia R, Dominguez K, Chen YQ, Sandfort T, Eshleman SH . Antiretroviral drug use and HIV drug resistance among MSM and transgender women in sub-Saharan Africa [HPTN 075]. AIDS. 2018, 32: 1301-1306

Zhang Y, Sivay MV, Hudelson SE, Clarke W, Breaud A, Wang J, Piwowar-Manning E, Agyei Y, Fogel JM, Hamilton EL, Selin A, MacPhail C, Kahn K, Gomez-Olive FX, Hughes JP, Pettifor A, Eshleman SH . Antiretroviral Drug Use and HIV Drug Resistance Among Young Women in Rural South Africa: HPTN 068. J Acquir Immune Defic Syndr. 2018, 79: 315-322